Full Text View
Tabular View
No Study Results Posted
Related Studies
Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia
This study is currently recruiting participants.
Study NCT00158223   Information provided by National Institute of Mental Health (NIMH)
First Received: September 7, 2005   Last Updated: October 23, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Schizophrenia
Psychotic Disorders
Additional conditions recognized in this trial
Disease
More general conditions related to this trial
Mental Disorders
Pathologic Processes
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
Pimozide
Placebo
Additional drug interventions recognized in this trial
Clozapine
More general drug interventions related to this trial
Anti-Dyskinesia Agents
Antipsychotic Agents
Central Nervous System Agents
Central Nervous System Depressants
Dopamine Agents
Dopamine Antagonists
GABA Agents
GABA Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Antagonists
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
National Institute of Mental Health (NIMH)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services